We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 8 februari 2018

Oncogene - Table of Contents alert Volume 37 Issue 6

If you are unable to see the message below, click here to view.

nature.com webcasts

Springer Nature presents a custom webcast on: Multiple Assays of the Anti-Apoptotic BCL-2 Family

Date: Wednesday, February 28, 2018 

Register for the webcast and live Q&A session 

Sponsored by: Merck 

Volume 37, Issue 6 (February 2018)

In this issue
Original Articles

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses

J Stebbing and D A Sanders

Oncogene 2018 37: 695-696; advance online publication, October 16, 2017; 10.1038/onc.2017.390

Full Text

Original Articles


FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis OPEN

M S Chattaragada, C Riganti, M Sassoe, M Principe, M M Santamorena, C Roux, C Curcio, A Evangelista, P Allavena, R Salvia, B Rusev, A Scarpa, P Cappello and F Novelli

Oncogene 2018 37: 697-709; advance online publication, October 23, 2017; 10.1038/onc.2017.358

Abstract | Full Text

Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer OPEN

W Han, S Gao, D Barrett, M Ahmed, D Han, J A Macoska, H H He and C Cai

Oncogene 2018 37: 710-721; advance online publication, October 23, 2017; 10.1038/onc.2017.385

Abstract | Full Text

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)

T Mitamura, S Pradeep, M McGuire, S Y Wu, S Ma, H Hatakeyama, Y A Lyons, T Hisamatsu, K Noh, A Villar-Prados, X Chen, C Ivan, C Rodriguez-Aguayo, W Hu, G Lopez-Berestein, R L Coleman and A K Sood

Oncogene 2018 37: 722-731; advance online publication, October 23, 2017; 10.1038/onc.2017.348

Abstract | Full Text

mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma

B Holmes, A Benavides-Serrato, R S Freeman, K A Landon, T Bashir, R N Nishimura and J Gera

Oncogene 2018 37: 732-743; advance online publication, October 23, 2017; 10.1038/onc.2017.360

Abstract | Full Text

Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer

L Gan, J Meng, M Xu, M Liu, Y Qi, C Tan, Y Wang, P Zhang, W Weng, W Sheng, M Huang and Z Wang

Oncogene 2018 37: 744-755; advance online publication, October 23, 2017; 10.1038/onc.2017.363

Abstract | Full Text

Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis OPEN

A Abbaci, H Talbot, S Saada, N Gachard, J Abraham, A Jaccard, D Bordessoule, A L Fauchais, T Naves and M O Jauberteau

Oncogene 2018 37: 756-767; advance online publication, October 23, 2017; 10.1038/onc.2017.365

Abstract | Full Text

SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis

Y Liu, H Zhou, R Zhu, F Ding, Y Li, X Cao and Z Liu

Oncogene 2018 37: 768-776; advance online publication, October 23, 2017; 10.1038/onc.2017.370

Abstract | Full Text

Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion

Y Otani, T Ichikawa, K Kurozumi, S Inoue, J Ishida, T Oka, T Shimizu, Y Tomita, Y Hattori, A Uneda, Y Matsumoto, H Michiue and I Date

Oncogene 2018 37: 777-786; advance online publication, October 23, 2017; 10.1038/onc.2017.373

Abstract | Full Text

Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia OPEN

Q Heydt, C Larrue, E Saland, S Bertoli, J-E Sarry, A Besson, S Manenti, C Joffre and V Mansat-De Mas

Oncogene 2018 37: 787-797; advance online publication, October 23, 2017; 10.1038/onc.2017.376

Abstract | Full Text

Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis

W Luo, C Xu, J Ayello, F Dela Cruz, J M Rosenblum, S L Lessnick and M S Cairo

Oncogene 2018 37: 798-809; advance online publication, October 23, 2017; 10.1038/onc.2017.378

Abstract | Full Text

Plk1 phosphorylation of Numb leads to impaired DNA damage response

C Shao, S-J Chien, E Farah, Z Li, N Ahmad and X Liu

Oncogene 2018 37: 810-820; advance online publication, October 23, 2017; 10.1038/onc.2017.379

Abstract | Full Text

RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1

S-H Chen, X Gong, Y Zhang, R D Van Horn, T Yin, L Huber, T F Burke, J Manro, P W Iversen, W Wu, S V Bhagwat, R P Beckmann, R V Tiu, S G Buchanan and S-B Peng

Oncogene 2018 37: 821-832; advance online publication, October 23, 2017; 10.1038/onc.2017.384

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature